Shuna Yao

423 total citations
30 papers, 271 citations indexed

About

Shuna Yao is a scholar working on Pathology and Forensic Medicine, Oncology and Surgery. According to data from OpenAlex, Shuna Yao has authored 30 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pathology and Forensic Medicine, 15 papers in Oncology and 7 papers in Surgery. Recurrent topics in Shuna Yao's work include Lymphoma Diagnosis and Treatment (16 papers), Viral-associated cancers and disorders (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Shuna Yao is often cited by papers focused on Lymphoma Diagnosis and Treatment (16 papers), Viral-associated cancers and disorders (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Shuna Yao collaborates with scholars based in China and United States. Shuna Yao's co-authors include Zhihua Yao, Yanyan Liu, Junfeng Chu, Zheng Yan, Haiying Wang, Shujun Yang, Yuanlin Xu, Haiying Wang, Wenping Zhou and Shuang Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Shuna Yao

27 papers receiving 266 citations

Peers

Shuna Yao
Vincenzo Famiglietti Italy
Liisa Chang United Kingdom
Murtuza Rampurwala United States
Raimondo Di Giacomo Italy
Yibo Cai China
Antonio Gnoni Italy
Umair Majeed United States
Shinichi Takada Japan
Kevin Furlong United States
Vincenzo Famiglietti Italy
Shuna Yao
Citations per year, relative to Shuna Yao Shuna Yao (= 1×) peers Vincenzo Famiglietti

Countries citing papers authored by Shuna Yao

Since Specialization
Citations

This map shows the geographic impact of Shuna Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuna Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuna Yao more than expected).

Fields of papers citing papers by Shuna Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuna Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuna Yao. The network helps show where Shuna Yao may publish in the future.

Co-authorship network of co-authors of Shuna Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Shuna Yao. A scholar is included among the top collaborators of Shuna Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuna Yao. Shuna Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yao, Shuna, Qingyao Shang, Heng Zhou, et al.. (2025). Designing Single-Arm Clinical Trials: Principles, Applications, and Methodological Considerations. PubMed. 7(3). 90–98. 1 indexed citations
2.
Yan, Zheng, Shuna Yao, Haiying Wang, et al.. (2023). Low incidence of hepatitis B virus reactivation in patients with hematological malignancies receiving novel anticancer drugs: A report from a high epidemic area and literature review. Journal of Microbiology Immunology and Infection. 56(4). 747–756. 1 indexed citations
3.
Yan, Zheng, Shuna Yao, Zhizhong Wang, et al.. (2023). Treatment of extranodal NK/T-cell lymphoma: From past to future. Frontiers in Immunology. 14. 1088685–1088685. 8 indexed citations
4.
Yao, Shuna, Zhihua Yao, Yan Zheng, et al.. (2023). Preliminary Results of a Phase Ⅱ Study of Lenalidomide Combined with Immunochemotherapy in Patients with Primary Central Nervous System Lymphoma. Blood. 142(Supplement 1). 1758–1758. 1 indexed citations
5.
6.
Yao, Zhihua, Yan Zheng, Shuna Yao, et al.. (2022). Preliminary Results of a Phase Ⅱ Study of Zanubrutinib Combined with Immunochemotherapy in Patients with CD79A/CD79B-Mutant Diffuse Large B-Cell Lymphoma. Blood. 140(Supplement 1). 3767–3768. 1 indexed citations
7.
Zhou, Wenping, Yuanlin Xu, Zhihua Yao, et al.. (2022). MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma. Leukemia. 36(7). 1861–1869. 18 indexed citations
8.
9.
Yan, Zheng, et al.. (2021). Primary Testicular Lymphoma with Central Nervous System Relapse Was Successfully Treated by a Chemo-Free Regimen: A Case Report and Literature Review. Cancer Management and Research. Volume 13. 9489–9500. 5 indexed citations
10.
Yan, Zheng, Wenping Zhou, Zhihua Yao, et al.. (2020). A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression. Biomarker Research. 8(1). 33–33. 11 indexed citations
11.
Yan, Zheng, Shuna Yao, Yanyan Liu, et al.. (2020). Durable Response to Sintilimab and Chidamide in a Patient With Pegaspargase- and Immunotherapy-Resistant NK/T-Cell Lymphoma: Case Report and Literature Review. Frontiers in Oncology. 10. 608304–608304. 20 indexed citations
12.
Wang, Haiying, Junfeng Chu, Peng Zhang, et al.. (2020). <p>Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma</p>. OncoTargets and Therapy. Volume 13. 1561–1568. 40 indexed citations
13.
Yang, Yuhuan, Shuna Yao, Zheng Yan, et al.. (2019). <p>Decitabine-containing G-CSF priming regimen overcomes resistance of primary mediastinal neoplasm from early T-cell precursors to conventional chemotherapy: a case report</p>. OncoTargets and Therapy. Volume 12. 7039–7044. 3 indexed citations
14.
Yao, Shuna, Junbo Li, Zhihua Yao, et al.. (2017). Extranodal involvement in young patients with diffuse large B-cell lymphoma: distribution, prognostic value and treatment options. Chinese Journal of Cancer Research. 29(1). 57–65. 11 indexed citations
15.
Yao, Zhihua, Yuan Tian, Haiying Wang, et al.. (2017). MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma. Tumor Biology. 39(6). 3726131641–3726131641. 52 indexed citations
16.
17.
Liu, Yanyan, Shuna Yao, Zhihua Yao, et al.. (2015). MicroRNAs are Related to Rituximab in Combination with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Resistance in Patients with Diffuse Large B-cell Lymphoma. SHILAP Revista de lepidopterología. 1(1). 6–6. 5 indexed citations
18.
Liu, Lei, et al.. (2014). Efficacy of gemcitabine combined with oxaliplatin, L-asparaginase and dexamethasone in patients with newly-diagnosed extranodal NK/T-cell lymphoma. Molecular and Clinical Oncology. 2(6). 1172–1176. 10 indexed citations
19.
Liu, Yanyan, Shuna Yao, Yan Zhao, et al.. (2010). PTENtumor suppressor plays less prognostic role thanP53tumor suppressor in diffuse large B-cell lymphoma. Leukemia & lymphoma. 51(9). 1692–1698. 10 indexed citations
20.
Yao, Zhihua, et al.. (2009). Analysis of clinical data and prognosis for 24 patients with primary parotid malignant lymphoma. 18(10). 616–618. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincenzo Famiglietti Breakdown of academic impact, for papers by Liisa Chang Breakdown of academic impact, for papers by Murtuza Rampurwala Breakdown of academic impact, for papers by Raimondo Di Giacomo Breakdown of academic impact, for papers by Yibo Cai Breakdown of academic impact, for papers by Antonio Gnoni Breakdown of academic impact, for papers by Umair Majeed Breakdown of academic impact, for papers by Shinichi Takada Breakdown of academic impact, for papers by Kevin Furlong
Rankless by CCL
2026